Granisetron
- 1 November 1991
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 42 (5) , 805-824
- https://doi.org/10.2165/00003495-199142050-00007
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- First Clinical Study of the Selective 5‐HT3 Antagonist, Granisetron (BRL 43694), in the Acute Treatment of Migraine HeadacheHeadache: The Journal of Head and Face Pain, 1991
- OndansetronDrugs, 1991
- Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: A summaryCancer Treatment Reviews, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Optimum Management of Nausea and Vomiting in Cancer ChemotherapyDrugs, 1987
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motilityDigestive Diseases and Sciences, 1986
- Extrapyramidal Reactions with High-Dose MetoclopramideNew England Journal of Medicine, 1983
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981